C. Jones-Burton

发表

An In-Depth Review of the Evidence Linking Dietary Salt Intake and Progression of Chronic Kidney Disease

G. Bakris, J. Fink, Shiraz I Mishra, 2006, American Journal of Nephrology.

Antithrombotic Therapy in Patients with Atrial Fibrillation and Acute Coronary Syndrome Treated Medically or with Percutaneous Coronary Intervention or Undergoing Elective Percutaneous Coronary Intervention: Insights from the AUGUSTUS Trial.

D. Xavier, B. Lewis, T. Potpara, 2019, Circulation.

Survival Benefit of Recombinant Human Erythropoietin Administration prior to Onset of End-Stage Renal Disease: Variations across Surrogates for Quality of Care and Time

M. Zhan, J. Fink, W. Lu, 2005, Nephron Clinical Practice.

Racial variations in erythropoietic response to epoetin alfa in chronic kidney disease and the impact of smoking.

S. Seliger, J. Fink, V. D. Hsu, 2005, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

Center effects in anemia management of dialysis patients.

M. Zhan, P. Langenberg, S. Seliger, 2007, Journal of the American Society of Nephrology : JASN.

Effects in Anemia Management of Dialysis Patients

M. Zhan, P. Langenberg, S. Seliger, 2007 .

The comparative efficacy of ezetimibe added to atorvastatin 10 mg versus uptitration to atorvastatin 40 mg in subgroups of patients aged 65 to 74 years or greater than or equal to 75 years

N. Wenger, O. Ben‐Yehuda, C. Jones-Burton, 2011, Journal of geriatric cardiology : JGC.

Does dietary salt increase the risk for progression of kidney disease?

G. Bakris, J. Fink, Shiraz I Mishra, 2005, Current hypertension reports.

Safety and efficacy of ezetimibe added on to rosuvastatin 5 or 10 mg versus up-titration of rosuvastatin in patients with hypercholesterolemia (the ACTE Study).

H. Bays, M. Davidson, C. Jones-Burton, 2011, The American journal of cardiology.

Cigarette Smoking and Incident Chronic Kidney Disease: A Systematic Review

S. Seliger, J. Fink, Shiraz I Mishra, 2007, American Journal of Nephrology.

Effects of the renin inhibitor MK-8141 (ACT-077825) in patients with hypertension.

P. Feig, Yabing Mai, C. Jones-Burton, 2010, Journal of the American Society of Hypertension : JASH.

The effects of adenosine A(1) receptor antagonism in patients with acute decompensated heart failure and worsening renal function: the REACH UP study.

P. Ponikowski, C. O'connor, M. Metra, 2010, Journal of cardiac failure.

Racial/ethnic disparity in kidney transplantation outcomes: influence of donor and recipient characteristics.

C. Jones-Burton, G. Ellison, B. Philosophe, 2009, Journal of the National Medical Association.

Efficacy and Safety of Ezetimibe Plus Rosuvastatin Versus Rosuvastatin Up-Titration in Hypercholesterolemic Patients at Risk for Atherosclerotic Coronary Heart Disease

H. Bays, M. Davidson, C. Jones-Burton, 2011 .

Safety and Efficacy Outcomes 3 Years After Switching to Belatacept From a Calcineurin Inhibitor in Kidney Transplant Recipients: Results From a Phase 2 Randomized Trial.

R. Manfro, N. Kamar, F. Vincenti, 2017, American journal of kidney diseases : the official journal of the National Kidney Foundation.

Urinary cotinine as an objective measure of cigarette smoking in chronic kidney disease.

J. Fink, T. Dowling, C. Jones-Burton, 2007, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

Lipid Lowering for Secondary Prevention of Cardiovascular Disease in Older Adults

J. Foody, C. Jones-Burton, A. Tershakovec, 2010, Drugs & aging.

Safety and efficacy of ezetimibe added to atorvastatin versus up titration of atorvastatin to 40 mg in Patients > or = 65 years of age (from the ZETia in the ELDerly [ZETELD] study).

N. Wenger, C. Jones-Burton, F. Zieve, 2010, The American journal of cardiology.

Nitric oxide decreases estradiol synthesis of rat luteinized ovarian cells: possible role for nitric oxide in functional luteal regression.

A. Jablonka-Shariff, L. Olson, C. Jones-Burton, 1996, Endocrinology.

Safety and efficacy of ezetimibe/simvastatin combination versus atorvastatin alone in adults ≥65 years of age with hypercholesterolemia and with or at moderately high/high risk for coronary heart disease (the VYTELD study).

J. Foody, A. Adewale, W. Brown, 2010, The American journal of cardiology.

Final Results From the Long-Term Extension (LTE) of the Belatacept Phase 2 Study in Kidney Transplantation.: Abstract# 2164

F. Vincenti, C. Larsen, B. Charpentier, 2014 .

Outcomes at 3-Years in EBV+ Recipients of UNOS Criteria ECD Kidneys From a Randomized Trial (BENEFIT-EXT) Comparing Belatacept vs Cyclosporine.: Abstract# A202

B. Charpentier, A. Durrbach, C. Jones-Burton, 2014 .

Antithrombotic Therapy in Patients With Atrial Fibrillation and Acute Coronary Syndrome Treated Medically or With Percutaneous Coronary Intervention or Undergoing Elective Percutaneous Coronary Intervention

D. Xavier, B. Lewis, T. Potpara, 2019 .

Safety and Efficacy Outcomes 3 Years After Switching to Belatacept From a Calcineurin Inhibitor in Kidney Transplant Recipients: Results From a Phase 2 Randomized Trial.

R. Manfro, N. Kamar, F. Vincenti, 2017, American journal of kidney diseases : the official journal of the National Kidney Foundation.

#4333 A PHASE 3, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY OF BION-1301 IN ADULTS WITH IGA NEPHROPATHY

V. Perkovic, J. Barratt, H. Trimarchi, 2023, Nephrology Dialysis Transplantation.